Three views on technology improving clinical trial efficiency
Marie Emms, vice president of site and patient participation at Syneos Health, tells us technology helped increase patient enrolment, improve diversity and inclusion, and boost retention rates for clinical trials after the pandemic. Still, she says a lot needs to be done to continue this upward trajectory.
“There’s an acknowledgement among companies that the paradigm of running clinical trials needs to evolve. One of the challenges within the industry is that changes take a long time to happen, but there have been some innovative solutions we’ve seen come through,” says Marie.
Keith Fern, vice president of corporate development at Elligo Health Research, and Matt Miller, CEO of StudyKIK, agree that the evolution of modern-day clinical trial operations need to continue, and data and technology is at the forefront of that progression.
Syneos Health, a fully integrated biopharmaceutical solutions organisation, was one of the companies helping adjust the clinical trial experience during the pandemic.
• Read the full article in pharmaphorum's Deep Dive digital magazine